feed,title,long_url,short_url
Benzinga,FDA Okays bluebird bio's $3M Gene Therapy For Rare Neurological Disorder In Boys: What Investors Should Know,https://benzinga.com/general/biotech/22/09/28905729/fda-just-okayed-bluebird-bios-3m-gene-therapy-for-rare-neurological-disorder-in-boys-what-investo,https://bit.ly/3DBme5Q
